These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 9375777)

  • 1. Should patients starting anticoagulant therapy be screened for missense mutations at Ala-10 in the factor IX propeptide?
    Peters J; Luddington R; Brown K; Baglin C; Baglin T
    Br J Haematol; 1997 Nov; 99(2):467-8. PubMed ID: 9375777
    [No Abstract]   [Full Text] [Related]  

  • 2. [An uncommon cause of severe soft tissue bleeding during phenprocoumon treatment].
    Neuhaus T; Hertfelder HJ; Hess L; Oldenburg J; Walger P; Vetter H
    Dtsch Med Wochenschr; 2001 Jun; 126(25-26):754-6. PubMed ID: 11455667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No indication for APTT screening in patients on oral anticoagulant therapy.
    van der Meer FJ; Vos HL; Rosendaal FR
    Thromb Haemost; 1999 Mar; 81(3):364-6. PubMed ID: 10102461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic predisposition to bleeding during oral anticoagulant therapy: evidence for common founder mutations (FIXVal-10 and FIXThr-10) and an independent CpG hotspot mutation (FIXThr-10).
    Oldenburg J; Kriz K; Wuillemin WA; Maly FE; von Felten A; Siegemund A; Keeling DM; Baker P; Chu K; Konkle BA; Lämmle B; Albert T;
    Thromb Haemost; 2001 Mar; 85(3):454-7. PubMed ID: 11307814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Massive muscle haematoma three months after starting vitamin K antagonist therapy for deep-vein thrombosis in an antithrombin deficient patient: another case of factor IX propeptide mutation.
    Jahns M; Friess D; Demarmels Biasiutti F; Kremer Hovinga JA; Alberio L; Oldenburg J; Lämmle B; Colucci G
    Thromb Haemost; 2011 Aug; 106(2):381-2. PubMed ID: 21655682
    [No Abstract]   [Full Text] [Related]  

  • 6. Factor IX gene analysis in 70 unrelated patients with haemophilia B: description of 13 new mutations.
    Attali O; Vinciguerra C; Trzeciak MC; Durin A; Pernod G; Gay V; Ménart C; Sobas F; Dechavanne M; Négrier C
    Thromb Haemost; 1999 Nov; 82(5):1437-42. PubMed ID: 10595634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Conundrum of "Warfarin Hypersensitivity": Prolonged Partial Thromboplastin Time From Factor IX Propeptide Mutation.
    Sekhri A; Lisinschi A; Furqan M; Palaniswamy C; Mukhi N; Gupta R; Nelson JC
    Am J Ther; 2016; 23(3):e911-5. PubMed ID: 24832385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital hypersensitivity to vitamin K antagonists due to FIX propeptide mutation at locus -10: a (not so) rare cause of bleeding under oral anticoagulant therapy in Switzerland.
    Ulrich S; Brand B; Speich R; Oldenburg J; Asmis L
    Swiss Med Wkly; 2008 Feb; 138(7-8):100-7. PubMed ID: 18293119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Missense mutations at ALA-10 in the factor IX propeptide: an insignificant variant in normal life but a decisive cause of bleeding during oral anticoagulant therapy.
    Oldenburg J; Quenzel EM; Harbrecht U; Fregin A; Kress W; Müller CR; Hertfelder HJ; Schwaab R; Brackmann HH; Hanfland P
    Br J Haematol; 1997 Jul; 98(1):240-4. PubMed ID: 9233593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the propeptide and gamma-glutamic acid domain of factor IX for in vitro carboxylation by the vitamin K-dependent carboxylase.
    Stanley TB; Wu SM; Houben RJ; Mutucumarana VP; Stafford DW
    Biochemistry; 1998 Sep; 37(38):13262-8. PubMed ID: 9748333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-fatal major bleeding during treatment with vitamin K antagonists: influence of soluble thrombomodulin and mutations in the propeptide of coagulation factor IX.
    van der Heijden JF; Rekké B; Hutten BA; van der Meer FJ; Remkes MG; Vermeulen M; Büller HR; Reitsma PH
    J Thromb Haemost; 2004 Jul; 2(7):1104-9. PubMed ID: 15219193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No impact of factor IX Ala-10 mutations in acenocoumarol-treated southern Europeans.
    Tàssies D; Monteagudo J; Maragall S; Ordinas A; Reverter JC
    Blood Coagul Fibrinolysis; 2005 Nov; 16(8):563-6. PubMed ID: 16269929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Warfarin treatment of a patient with coagulation factor IX propeptide mutation causing warfarin hypersensitivity.
    Kristensen SR
    Blood; 2002 Oct; 100(7):2676-7. PubMed ID: 12360981
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular analysis of hemophilia B in Poland: 12 novel mutations of the factor IX gene.
    Wulff K; Bykowska K; Lopaciuk S; Herrmann FH
    Acta Biochim Pol; 1999; 46(3):721-6. PubMed ID: 10698280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation factor IX propeptide mutations causing coumarin hypersensitivity: identification of female alanine-10 valine heterozygotes.
    Bestmann L; Züger M; Oldenburg J; Bühler D; Maly FE
    Thromb Haemost; 2001 Mar; 85(3):567-8. PubMed ID: 11307837
    [No Abstract]   [Full Text] [Related]  

  • 16. Spectrum of factor IX gene mutations causing haemophilia B from India.
    Ghosh K; Quadros L; Shetty S
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):333-6. PubMed ID: 19357501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic heterogeneity of molecular events in human coagulation factor IX in Asian Indians. Mutation in brief #965. Online.
    Mahajan A; Chavali S; Ghosh S; Kabra M; Chowdhury MR; ; Bharadwaj D
    Hum Mutat; 2007 May; 28(5):526. PubMed ID: 17397055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic risk factors for inhibitors to factors VIII and IX.
    Oldenburg J; Pavlova A
    Haemophilia; 2006 Dec; 12 Suppl 6():15-22. PubMed ID: 17123389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel missense mutation in the coagulation factor IX catalytic domain associated with severe haemophilia B--Factor IXDelhi.
    Mahajan A; Sharma A; Chavali S; Kabra M; Chowdhury MR; Srinivasan N; Bharadwaj D
    Haemophilia; 2004 Sep; 10(5):550-2. PubMed ID: 15357782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of hemophilia B in North Indian families: identification of novel and recurrent molecular events in the factor IX gene.
    Mahajan A; Chavali S; Kabra M; Chowdhury MR; Bharadwaj D
    Haematologica; 2004 Dec; 89(12):1498-503. PubMed ID: 15590401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.